Related Experiment Video

Updated: Jun 19, 2026

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

P2X7-mediated chemoprevention of epithelial cancers

George I Gorodeski1

  • 1Case Western Reserve University, Oncology and the Comprehensive Cancer Center, Department of Reproductive Biology, Physiology and Biophysics, 11100 Euclid Avenue, Cleveland, Ohio 44106, USA. george.gorodeski@case.edu

Expert Opinion on Therapeutic Targets
|October 23, 2009
PubMed
Abstract

Insights

Targeting the P2X7 receptor system to enhance apoptosis shows promise for preventing and treating epithelial cancers. This approach has demonstrated significant antitumor effects in preclinical models, paving the way for new therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Anti-apoptotic mechanisms are crucial in cancer development.
  • The P2X7 receptor system modulates apoptosis in epithelial cells.
  • Augmenting P2X7-mediated apoptosis is a potential strategy for epithelial cancer chemoprevention and treatment.

Purpose of the Study:

  • Review progress in clinical applications of P2X7-mediated apoptosis therapies.
  • Discuss P2X7-mediated apoptosis in epithelial cancer prevention and growth control.
  • Summarize in vivo data from mouse skin cancer models.

Main Methods:

  • Literature search of PubMed and MEDLINE databases.
  • Review and synthesis of existing research data.

Main Results:

  • Understanding P2X7-mediated apoptosis mechanisms offers a novel strategy for targeting skin neoplasia.
  • Upregulation of apoptosis is directly linked to cancer chemoprevention.
  • Significant antitumor efficacy observed in rodent cancer models.

Conclusions:

  • P2X7 receptor modulation represents a promising therapeutic strategy for epithelial cancers.
  • Preclinical data supports the translation of P2X7-mediated apoptosis knowledge into clinical therapies.
  • This approach offers a targeted strategy for skin cancer treatment and prevention.

More Related Videos

Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue10:11

Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...